Skip to main content
. 2024 Jan 29;28(2):152–164. doi: 10.5005/jp-journals-10071-24623

Table 1.

Demographics and clinical characteristics of ICU patients and HDU patients with MDAIs

Characteristics Total patients [N = 90, n (%)] ICU patients with MDAIs [N = 46, n (%)] HDU patients with MDAIs [N = 44, n (%)]
Age (years)
  Mean (SD) 51.8 (13.2) 54.2 (12.5) 49.3 (13.7)
  Median (P25–P75) 55 (43.1–62.3) 56 (43.8–62.2) 51 (38.3–32.8)
Gender
  Male 61 (67.8) 32 (35.6) 29 (32.2)
  Female 29 (32.2) 14 (15.6) 15 (16.7)
Comorbidities
  Chronic kidney disease 74 (82.2) 33 (36.6) 41 (45.5)
  Hypertension 71 (78.9) 40 (44.4) 31 (34.4)
  Uncontrolled diabetes mellitus 41 (45.6) 26 (28.9) 15 (16.7)
  Ischemic heart disease 28 (31.1) 21 (23.3) 7 (7.8)
  Neurological disease 10 (11.1) 7 (7.8) 3 (3.3)
  Chronic liver disease 7 (7.8) 5 (5.6) 2 (2.2)
  Asthma or COPD exacerbation 7 (7.8) 3 (3.3) 4 (4.4)
Immune status
  Immunocompromised 62 (68.9) 40 (86.9) 22 (50)
  Immunocompetent 28 (31.1) 11 (23.9) 17 (38.6)
Types of MDAI (N = 104), n (%)
  CLABSI 64 (61.5) 25 (46.3) 39 (78)
  CAUTI 21 (20.2) 10 (18.5) 11 (22)
  VAP 19 (18.3) 19 (35.2)
Site of venous cannulation
  Femoral vein 37 (41.1) 18 (20) 19 (21.1)
  Jugular vein 24 (26.6) 14 (15.5) 10 (11.1)
  Basilic vein 20 (22.2) 09 (10) 11 (12.2)
  Subclavian vein 09 (10.6) 05 (5.6) 04 (4.4)
Duration of catheterization (d)
  Median (P25–P75) 10 (7–18) 10 (6–13) 9 (7–18)
  ≥12 days 40 (44.4) 22 (47.8) 18 (40.9)
  <12 days 50 (55.6) 24 (52.2) 26 (59.1)
Length of ICU/HDU hospitalization (d)
  Median (P25–P75) 7 (4–9) 7 (5–9) 6 (4–8)
ICU/HDU hospitalization
  ≥7 days 57 (63.3) 34 (73.9) 23 (52.3)
  Endotracheal intubation 12 (26.1)
  Tracheostomy 7 (15.2)
Mortality rate
  Survived: Not survived 88:2 44:2 44:0

CLABSI, central-line associated bloodstream infection; CAUTI, catheter associated urinary tract infection; COPD, chronic obstructive pulmonary disease; HDU, high dependency unit; ICU, intensive care unit; VAP, ventilator associated pneumonia